Loading…

Willis Towers WatsonWTWCompetitor analysis, valuation and peers

United States · USD·Financials›Insurance Brokers/Services

Global insurance broker and advisory firm focused on risk, benefits and retirement/pension consulting.

Momentum strong 78
Mkt cap
$30.3B
US dollars, full cap
Free float
100%
of shares outstanding
$/day
$192M
20-day average traded
P/B
3.91×
price to book
ROE
20.2%
delivered
Implied ROE
19.0%
what the price asks
Next earnings
95 days
9 Feb 2027
Close · USD$328.86
1D-2.3%
1W+1.4%
1M+10.4%
3M-4.1%
6M+28.8%
YTD+0.8%
1Y+2.8%
ATR %2.6%
Beta-0.10
52w lowhigh6.4% off high

What Willis Towers Watson does

Global insurance broker and advisory firm focused on risk, benefits and retirement/pension consulting.

Is paid mainly by clients as fees for advice and by insurers as commissions for placing business, while the retirement-consulting and benefits side earns recurring fees from employers. It was formed in 2016 by the merger of insurance broker Willis and consultancy Towers Watson, and a planned 2021 sale to Aon was abandoned after regulatory opposition.

Products and services

  • Corporate risk & broking
  • Health, wealth & career consulting
  • Reinsurance broking
  • Risk analytics software

Customers

  • Large corporations
  • Employers
  • Insurers/reinsurers

Where it sits in the supply chain

  • Insurance distribution
  • Insurance broking
  • Benefits/retirement consulting

What could go right

  • Pension de-risking demand
  • Hard commercial insurance market

What could go wrong

  • Lagging growth vs. peers Aon/Marsh
  • Integration/turnaround execution risk

Moat: narrow (scale, distribution, brand). Scale in global placement and pension/benefits expertise create switching costs for large clients.

Headquarters: London, United Kingdom · Founded: 2016 · Employees: 46,900

Named competitors

Willis Towers Watson at a glance

Size Willis Towers Watson (WTW) is a United States Financials company (Insurance Brokers/Services) with a market value of $30.3B, the 360th largest of 3,117 United States companies the cockpit tracks. Shares closed at $328.86 on 6 Nov 2026.

Performance Over six months the shares gained 28.8%, against +25.5% for the median peer and -1.1% for the United States market (cap-weighted) — 3rd highest of 8 in its peer set.

Growth Revenue grew 4.8% over the last twelve months (peer median +7.6%); the operating margin is 23.6% (peer median 20.4%).

Valuation It trades at 3.91× book value against a peer median of 3.00× (4th most expensive of 8).

Price implies The share price implies a return on equity of about 19.0%; Willis Towers Watson delivers 20.2%, so the price asks less than the business earns today.

Backlog Backlog (remaining performance obligations) was $1.65B at 30 Sep 2026, up 2% on a year earlier — 0.2 years of trailing revenue. Backlog detail →

Short interest Short interest is 2.4% of the free float (15 Oct 2026).

Next results Next results expected around 9 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012014011 May 202611 Aug 20266 Nov 2026WTW 132Peer median 127
Six months, rebased to 100: Willis Towers Watson against the median of its 7 peers (local-currency closes).

Willis Towers Watson financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$10.3B$9.71B$9.93B$9.48B$8.86B
Revenue growth—-2%+5%+7%—
Gross profit$8.37B$7.88B$7.64B$7.16B$6.52B
EBITDA$2.86B$2.69B$2.58B$2.33B$1.88B
Net income$1.56B$1.60B-$98.0M$1.05B$1.07B
Free cash flow$1.74B$1.55B$1.27B$1.19B$674M
Capital expenditure$241M$229M$245M$242M$204M
Total debt$7.10B$6.90B$5.93B$5.94B$5.48B

Quarterly statements and history in the cockpit →

Willis Towers Watson competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

+20%+40%+10%+20%BROTRYGAONAJGGRYANMRSHWTW6-month return →1-month return →
Up and to the right = strong over both horizons. Willis Towers Watson is the large dot.

Fundamentals: return on equity against price-to-book

10%20%30%40%50×100×BROTRYGAONAJGGRYANMRSHWTWReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. Willis Towers Watson is the large dot.

Capital: ROE delivered against the ROE the price implies

20%40%60%20%40%60%BROTRYGAONAJGGRYANMRSHWTWROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. Willis Towers Watson is the large dot.

Willis Towers Watson competitors and peer comparison

Head to head with its named competitors (WTW vs MRSH vs AON vs AJG)
CompanyMarket cap6M returnRevenue growthROEPrice / bookImplied ROE
Willis Towers Watson WTW$30.3B+29%+5%20%3.91×19.0%
Marsh McLennan MRSH$97.4B+25%+8%27%6.64×32.7%
Aon AON$71.0B+7%+3%44%7.03×38.0%
Arthur J. Gallagher & AJG$72.2B+42%+26%7%3.00×15.6%
Brown & Brown BRO$23.9B+28%+26%10%1.87×11.3%

How Willis Towers Watson compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Willis Towers Watson against its 7 peers (data as of 6 Nov 2026)
MeasureWTWPeer medianRank in peer set
1-month return+10.4%+15.9%2nd lowest of 8
6-month return+28.8%+25.5%3rd highest of 8
Return on equity20.2%14.7%3rd highest of 8
Price / book3.91×3.00×4th most expensive of 8
Trailing P/E20.1×22.8×3rd cheapest of 8
ROE the price implies19.0%16.5%4th most demanding of 8
ROE delivered20.2%14.7%3rd highest of 8

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
Willis Towers Watson WTWUnited States$30.3B+29%+5%20%3.91×19.0%20.2%
Brown & Brown BROUnited States$23.9B+28%+26%10%1.87×11.3%9.6%
Tryg A/S TRYG.CODenmark$14.2B+10%+5%12%2.61×8.1%12.4%
Aon AONUnited States$71.0B+7%+3%44%7.03×38.0%43.6%
Arthur J. Gallagher & AJGUnited States$72.2B+42%+26%7%3.00×15.6%7.2%
Assicurazioni Generali G.MIItaly$73.8B+12%-8%15%2.06×16.5%14.7%
Ryan Specialty RYANUnited States$12.0B+52%+9%19%12.86×61.4%19.4%
Marsh McLennan MRSHUnited States$97.4B+25%+8%27%6.64×32.7%27.1%

Willis Towers Watson backlog

Willis Towers Watson reported $1.65B of remaining performance obligations at 30 Sep 2026, up 2% from a year earlier and up 11% from the previous quarter. That is 0.2 years of trailing revenue already under contract. Book-to-bill last quarter: 1.07.

Questions

Who are Willis Towers Watson's main competitors?
Named competitors: Marsh McLennan (MRSH), Aon (AON), Arthur J. Gallagher (AJG), Brown & Brown (BRO). The cockpit's measured peer set (industry) also includes Brown & Brown (BRO), Tryg A/S (TRYG.CO), Aon (AON), Arthur J. Gallagher & (AJG), Assicurazioni Generali (G.MI), Ryan Specialty (RYAN).
Is Willis Towers Watson expensive compared with its peers?
On price / book it trades at 3.91× against a peer median of 3.00×, 4th most expensive of 8 in its peer set. The share price implies a return on equity of about 19.0%; Willis Towers Watson delivers 20.2%, so the price asks less than the business earns today.
How has Willis Towers Watson stock performed?
Over six months to 6 Nov 2026 the shares returned +28.8% against +25.5% for the median peer; over one year +2.8%.
What is Willis Towers Watson's backlog?
Willis Towers Watson's remaining performance obligations (contracted revenue not yet recognised) were $1.65B at 30 Sep 2026, +2% on a year earlier.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.